Waverley Pharma Inc (WAVE.V) faced a challenging week, with significant price movement and a recent leadership change.
Waverley Pharma Inc has experienced a notable decline in its stock price over the past week, dropping 25%. This downturn comes amidst a backdrop of company news, including a recent change in the Chief Financial Officer position. As investors assess the implications of these developments, it’s essential to look at the technical picture and overall market sentiment surrounding Waverley Pharma.
Waverley Pharma Inc
WAVE.V
WAVE.V
Waverley Pharma Inc
WealthAwesomeMarket cap
$540,000
52W high
$0.03
52W low
$0.01
1W change
+100.00%
Beta
1.46
Analyst Price Targets
Based on analyst covering WAVE · as of Sep 17, 2026
Wall Street analysts forecast WAVE stock price to rise 49900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$10.00
+49900.0% Upside
Current Price
C$0.02
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WAVE's historical volatility
30-Day Vol
518.1%
Annualized
90-Day Vol
520.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.00 – C$0.13 |
| 60 trading days | C$0.02 | C$0.00 – C$0.28 |
| 90 trading days | C$0.02 | C$0.00 – C$0.53 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: While Waverley Pharma Inc has seen a significant decline in its stock price this week, understanding the technical indicators and recent company news can help investors navigate potential volatility in the healthcare sector.
Waverley Pharma's stock is down 25% this week.
With a current market cap of C$810,000, Waverley Pharma is trading at C$0.01, significantly below its 52-week high of C$0.03.
Bull case
The recent acquisition of C & R Pharmacy could help Waverley Pharma grow in the U.S. market. This move may boost its revenue and improve long-term prospects.
Bear case
The resignation of the CFO and ongoing financial challenges, including a negative profit margin and return on equity, raise concerns about the company's operational stability and financial health.
Recent Price Action
Waverley Pharma Inc's stock closed at C$0.01, reflecting a 25% decline over the past week. This downward trend has raised concerns among investors about the company’s market position, particularly following the announcement of a leadership change.
Catalysts Behind the Move
The recent resignation of Chief Financial Officer Haaris Uddin, effective July 24, 2026, has likely contributed to the stock's volatility. Additionally, the company's acquisition of C & R Pharmacy, announced on September 23, 2024, may present growth opportunities, although investors remain cautious given the current financial metrics.
Technical Picture
Waverley Pharma is currently trading below its 50-day and 200-day moving averages of C$0.02, indicating a bearish trend. The stock’s 52-week range is C$0.01 to C$0.03, with the current price at the lower end of this spectrum, suggesting limited upward momentum. The beta of 1.22 indicates higher volatility compared to the market.
Insider Activity
There have been no recent insider transactions reported, which may suggest a lack of confidence or interest from current executives in purchasing shares amid the leadership changes.
Summary of Price Action
Waverley Pharma Inc's last close was C$0.01, reflecting a 1D change of +0.00%. The stock's performance over the past week has raised questions about the company's stability and future growth prospects.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
